Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine versus placebo for problematic sexual arousal in adult men in prison
ISRCTN91246381Phase 3Not yet recruiting
- Sponsor
- Nottingham Trent University
- Start
- Jan 2027
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Sexual Arousal Disorder comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
fluoxetine
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on ISRCTN91246381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91246381.